Cancer News and Research

Latest Cancer News and Research

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

Can-Fite announces favorable data from further analysis of CF101 Phase II/III study in patients with psoriasis

OncoGenex terminates agreement with Teva, regains rights to custirsen

OncoGenex terminates agreement with Teva, regains rights to custirsen

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

Findings open pathway to studying bat brains to understand certain human language disorders

Findings open pathway to studying bat brains to understand certain human language disorders

New analysis finds that rates of health insurance coverage vary by demographics, cancer type

New analysis finds that rates of health insurance coverage vary by demographics, cancer type

Persistent enlarged lymph glands in the neck may indicate cancer

Persistent enlarged lymph glands in the neck may indicate cancer

Large majority of people in the world lack access to safe, affordable surgery and anaesthesia

Large majority of people in the world lack access to safe, affordable surgery and anaesthesia

Men who receive brachytherapy more likely to be cancer-free five years later

Men who receive brachytherapy more likely to be cancer-free five years later

Researchers move one step closer to developing effective radiotherapy for lung cancer

Researchers move one step closer to developing effective radiotherapy for lung cancer

Increasing radiotherapy can significantly improve survival for children with intracranial ependymoma

Increasing radiotherapy can significantly improve survival for children with intracranial ependymoma

Brachytherapy improves overall survival for women with inoperable early stage endometrial cancer

Brachytherapy improves overall survival for women with inoperable early stage endometrial cancer

Humanized mouse model may lead to better anti-cancer therapies

Humanized mouse model may lead to better anti-cancer therapies

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Birmingham City University event to focus on digital future of NHS

Birmingham City University event to focus on digital future of NHS

AUDs have negative prognostic outcome with higher mortality risks in patients with HCV infection

AUDs have negative prognostic outcome with higher mortality risks in patients with HCV infection

New computational model helps study how emerging metastatic tumors interact with immune system

New computational model helps study how emerging metastatic tumors interact with immune system

Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease

Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease

iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.